Roth ME - Search Results

1

Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2.

Geller DS, Singh MY, Zhang W, Gill J, Roth ME, Kim MY, Xie X, Singh CK, Dorfman HD, Villanueva-Siles E, Park A, Piperdi S, Gorlick R. Geller DS, et al. Among authors: roth me. Clin Cancer Res. 2015 Jul 1;21(13):3003-12. doi: 10.1158/1078-0432.CCR-14-0986. Epub 2014 Dec 3. Clin Cancer Res. 2015. PMID: 25472999

2

Pediatric oncologists' views toward the use of complementary and alternative medicine in children with cancer.

Roth M, Lin J, Kim M, Moody K. Roth M, et al. J Pediatr Hematol Oncol. 2009 Mar;31(3):177-82. doi: 10.1097/MPH.0b013e3181984f5a. J Pediatr Hematol Oncol. 2009. PMID: 19262243

3

An assessment of the current state of palliative care education in pediatric hematology/oncology fellowship training.

Roth M, Wang D, Kim M, Moody K. Roth M, et al. Pediatr Blood Cancer. 2009 Oct;53(4):647-51. doi: 10.1002/pbc.22110. Pediatr Blood Cancer. 2009. PMID: 19449397

4

Career burnout among pediatric oncologists.

Roth M, Morrone K, Moody K, Kim M, Wang D, Moadel A, Levy A. Roth M, et al. Pediatr Blood Cancer. 2011 Dec 15;57(7):1168-73. doi: 10.1002/pbc.23121. Epub 2011 May 5. Pediatr Blood Cancer. 2011. PMID: 21548010

5

Attitudes and practices of pediatric oncologists regarding methadone use in the treatment of cancer-related pain: results of a North American Survey.

Roth M, Davies D, Friebert S, Wang D, Kim M, Zelcer S. Roth M, et al. J Pediatr Hematol Oncol. 2013 Mar;35(2):103-7. doi: 10.1097/MPH.0b013e318279e492. J Pediatr Hematol Oncol. 2013. PMID: 23242323

6

Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma.

Roth M, Linkowski M, Tarim J, Piperdi S, Sowers R, Geller D, Gill J, Gorlick R. Roth M, et al. Cancer. 2014 Feb 15;120(4):548-54. doi: 10.1002/cncr.28461. Epub 2013 Oct 25. Cancer. 2014. PMID: 24166473 Free PMC article.

7

Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma.

Cao Y, Roth M, Piperdi S, Montoya K, Sowers R, Rao P, Geller D, Houghton P, Kolb EA, Gill J, Gorlick R. Cao Y, et al. PLoS One. 2014 Aug 29;9(8):e106249. doi: 10.1371/journal.pone.0106249. eCollection 2014. PLoS One. 2014. PMID: 25170759 Free PMC article.

8

Variability in the reported management of pulmonary metastases in osteosarcoma.

Bhattasali O, Vo AT, Roth M, Geller D, Randall RL, Gorlick R, Gill J. Bhattasali O, et al. Cancer Med. 2015 Apr;4(4):523-31. doi: 10.1002/cam4.407. Epub 2015 Jan 28. Cancer Med. 2015. PMID: 25626877 Free PMC article.

9

Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma.

Poon VI, Roth M, Piperdi S, Geller D, Gill J, Rudzinski ER, Hawkins DS, Gorlick R. Poon VI, et al. Clin Sarcoma Res. 2015 Jan 24;5(1):4. doi: 10.1186/s13569-014-0020-9. eCollection 2015. Clin Sarcoma Res. 2015. PMID: 25642322 Free PMC article.

10

Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma.

Roth M, Barris DM, Piperdi S, Kuo V, Everts S, Geller D, Houghton P, Kolb EA, Hawthorne T, Gill J, Gorlick R. Roth M, et al. Pediatr Blood Cancer. 2016 Jan;63(1):32-8. doi: 10.1002/pbc.25688. Epub 2015 Aug 25. Pediatr Blood Cancer. 2016. PMID: 26305408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters